Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial
Abroad (travel likely)Recruiting
Conditions
Interstitial Lung Disease (ILD) · Fibrotic Interstitial Lung Disease · Idiopathic Pulmonary Fibrosis (IPF) · Progressive Pulmonary Fibrosis · Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hospital General de Granollers, Granollers, Barcelona, Spain
Study leads
Jaume Bordas-Martinez, MD, PhD
Principal Investigator
Hospital General de Granollers